468
Views
5
CrossRef citations to date
0
Altmetric
Review

Mass spectrometry in leukemia research and treatment

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gail J. Roboz & John Roboz. (2016) The application of mass spectrometry to leukemia drug discovery. Expert Opinion on Drug Discovery 11:11, pages 1029-1032.
Read now

Articles from other publishers (4)

Marco Agostini, Pietro Traldi & Mahmoud Hamdan. (2023) Mass Spectrometry Contribution to Pediatric Cancers Research. Medicina 59:3, pages 612.
Crossref
Maria Hernandez-Valladares, Øystein Bruserud & Frode Selheim. (2020) The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives. International Journal of Molecular Sciences 21:18, pages 6830.
Crossref
Ina Nepstad, Kimberley Joanne Hatfield, Ida Sofie Grønningsæter & Håkon Reikvam. (2020) The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells. International Journal of Molecular Sciences 21:8, pages 2907.
Crossref
Maria Hernandez-Valladares, Elise Aasebø, Frode Selheim, Frode Berven & Øystein Bruserud. (2016) Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia. Proteomes 4:3, pages 24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.